Potassium tetraiodoplatinate

From Wikipedia, the free encyclopedia

Potassium tetraiodoplatinate
Identifiers
3D model (JSmol)
  • InChI=1S/4HI.2K.Pt/h4*1H;;;/q;;;;2*+1;+2/p-4
    Key: WYVJXXSNNPZRSS-UHFFFAOYSA-J
  • dihydrate: InChI=1S/4I.2K.2H2O.Pt/h;;;;;;2*1H2;/q4*-1;2*+1;;;+2
    Key: FVUALNGXMHIQHF-UHFFFAOYSA-N
  • [K+].[K+].[I-][Pt+2]([I-])([I-])[I-]
  • dihydrate: [K+].[K+].[I-][Pt+2]([I-])([I-])[I-].O.O
Properties
H4I4K2O2Pt
Molar mass 816.928 g·mol−1
Appearance black solid
Density 4.31 g/cm3[1]
Related compounds
Other anions
Potassium tetrachloroplatinate
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Potassium tetraiodoplatinate is the inorganic compound with the formula K2PtI4·(H2O)2. It is the potassium salt of tetraiodoplatinate, a square planar complex of platinum(II). The compound crystallizes from water as the dihydrate,[1] whereas the related chloride and bromide K2PtCl4 and K2PtBr4 are obtained only as the anhydrous salts.

It reacts with amines and with ammonia to give charge-neutral derivatives PtI2(RNH2)2.[2] The compound is prepared by the salt metathesis reaction of potassium iodide and potassium tetrachloroplatinate:[3]

K2PtCl4 + 4 KI → K2PtI4 + 4 KCl

Potassium tetraiodoplatinate is a precursor to the anticancer drug cisplatin.

Related Articles

Wikiwand AI